Erlamide 60mg Tablet

About

Erlamide 60mg Tablet is an advanced androgen receptor inhibitor used in the treatment of prostate cancer. It works by binding to androgen receptors in cancer cells, preventing androgens (male hormones) from stimulating tumor growth. This action effectively blocks the signaling pathways that drive prostate cancer progression, leading to reduced tumor size and slowed disease advancement. Erlamide is typically prescribed for patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk for metastatic disease, or for metastatic castration-sensitive prostate cancer (mCSPC). Its oral administration offers convenience, and it is often used in conjunction with androgen deprivation therapy (ADT) to enhance therapeutic outcomes and improve patient survival rates. Regular monitoring of prostate-specific antigen (PSA) levels and other clinical parameters is essential during treatment to assess efficacy and manage potential side effects.

Uses

• Non-metastatic castration-resistant prostate cancer
• Metastatic castration-sensitive prostate cancer
• Advanced prostate cancer
• Hormone-sensitive prostate cancer

Directions For Use

Take orally once daily with or without food, as directed by your physician. Do not crush, chew, or split the tablet.

Benefits

• Delays metastasis in nmCRPC
• Improves overall survival in mCSPC
• Reduces risk of skeletal-related events
• Effective in slowing disease progression
• Oral administration for patient convenience
• Can be used with androgen deprivation therapy

Side Effects

• Fatigue
• Rash
• Hypertension
• Diarrhea
• Nausea
• Decreased appetite
• Arthralgia
• Hot flashes
• Hypothyroidism
• Seizures
• Falls
• Fractures

Safety Measures

• Alcohol - Avoid or limit alcohol consumption due to potential for increased side effects and liver strain.
• Pregnancy - Contraindicated in pregnant women; can cause fetal harm. Use effective contraception during treatment.
• Breastfeeding - Not recommended; unknown if excreted in breast milk and potential for serious adverse reactions in infants.
• Liver - Use with caution in patients with hepatic impairment; dose adjustment may be necessary.
• Kidney - Use with caution in patients with renal impairment; dose adjustment may be necessary.
• Lung - Monitor for interstitial lung disease, a rare but serious pulmonary adverse event.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.